Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Cat-PAD, ToleroMune cat allergy therapy
Also known as: ToleroMune Cat Dander
print preview
bookmark
share with colleague
General Information
Company
Circassia Ltd.
Description
T cell vaccine using ToleroMune T cell epitope desensitization technology
Molecular Target
Mechanism of Action
Vaccine
Latest Stage of Development
Phase III
Indication
Allergy
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy